Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. September 2024 04:00 ET | Quelle: Abingworth

Abingworth appoints Robert DeBenedetto as Managing Director – Clinical Co-Development

London, UK and New York, USA, September 10, 2024 - Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ: CG), today announced the...
29. Februar 2024 07:00 ET | Quelle: Abingworth

Abingworth Announces a Strategic Development Financing Agreement with Gilead Sciences; Establishes Joint Steering Committee between Launch Therapeutics and Gilead Sciences

London, UK and New York, USA, February 29, 2024 - Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced a strategic...
30. Oktober 2023 04:00 ET | Quelle: Abingworth

Abingworth raises $356 million for new Clinical Co-Development Co-Investment Fund (CCD-CIF)

Abingworth extends its capital base for late-stage clinical programs with pharma and biotech partners London, UK and New York, USA, October 30, 2023 - Abingworth, a leading international life...